Singapore markets closed
Straits Times Index
3,192.35 -16.51 (-0.51%) S&P 500
4,241.21 -47.18 (-1.10%) Dow
33,135.13 -298.22 (-0.89%) Nasdaq
13,121.25 -186.53 (-1.40%) Bitcoin USD
27,386.95 -945.54 (-3.34%) CMC Crypto 200
585.94 -4.03 (-0.68%)
LLY Oct 2023 360.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 12:36PM EDT. Market open.
| Previous close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.0500 |
| Strike | 360.00 |
| Expiry date | 2023-10-20 |
| Day's range | 0.0500 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 3.08k |
ZacksLilly's (LLY) Eczema Candidate Lebrikizumab Faces FDA Rejection
Lilly (LLY) gets a CRL for the eczema candidate, lebrikizumab, based on inspection findings at a third-party manufacturer.
ReutersEli Lilly to buy cancer-focused Point Biopharma for $1.4 billion
Lilly has been bolstering its pipeline through small deals as its cancer therapy Alimta faces fierce competition from copycat versions while betting on potential blockbuster drug tirzepatide, or Mounjaro, to drive growth. Point Biopharma is currently testing radioligand therapy candidates, PNT2002 and PNT2003, in late-stage studies. The experimental therapies combine radioactive particles that kill cells with molecules that attach themselves to the tumors.
ZacksACM Research and Advance Auto Parts have been highlighted as Zacks Bull and Bear of the Day
ACM Research and Advance Auto Parts have been highlighted as Zacks Bull and Bear of the Day.
© 2023 Yahoo. All rights reserved.
